Webinars & Online Seminars
An online learning resource
Eurofins DiscoverX offers a number of upcoming and previously recorded webinars, recorded online meetings and presentations with our scientists that cover a variety of relevant topics, tools and data analysis techniques.
View our new educational videos, that are no more than 30 minutes in length, by visiting our Knowledge-Based Videos page.
|
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|
27
| 28
| 29
| 30
| 1
| 2
| 3
|
4
| 5
| 6
| 7
| 8
| 9
| 10
|
11
| 12
| 13
| 14
| 15
| 16
| 17
|
18
| 19
| 20
| 21
| 22
| 23
| 24
|
25
| 26
| 27
| 28
| 29
| 30
| 31
|
1
| 2
| 3
| 4
| 5
| 6
| 7
|
No data found
Below is a list of our most popular webinar series available for 'on-demand' viewing.
Loading...
| Event Date ▼ |
Event Name |
PDF Link |
Webinar Link |
| July 28, 2022 |
Roundtable Webinar: Accelerating Your Biologics Therapeutics Development with Bioassays
|
|
|
| June 16, 2022 |
Webinar: Cytotoxicity Bioassays – Measuring Antibody-Mediated Direct Cell Death
|
|
|
| February 23, 2022 |
Webinar: Unlocking Orphan GPCRs with an Innovative Forward Trafficking Approach – 45 min. + 30 min. Q&A
|
|
|
| July 28, 2021 |
Webinar: Automating Functional Cell-based Bioassays: Assay Reproducibility and Performance for Potency Testing Programs - 45 min.
|
|
|
| March 30, 2021 |
Webinar: Novel Small Molecule Inhibitors of Oncogenic SHP2 Variants Characterized by Cellular Target Engagement - 45 min.
|
|
|
| October 28, 2020 |
Webinar: Accelerating COVID-19 Drug Discovery: Qualified Cell-Based Assays for Proinflammatory Cytokines - 45 min.
|
|
|
| June 17, 2020 |
Webinar: Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways - 30 min.
|
|
|
| February 26, 2020 |
Webinar: Protein Degradation (PROTACs/CRISPR) Assays - 60 min.
|
|
|
| April 19, 2017 |
Webinar: Combining Target-Based and Phenotypic Discovery Assays for Drug Repurposing - 40 min.
What will be covered?
- Using phenotypic profiling to characterize clinically successful drugs for a given indication
- Combining target-based and phenotypic data to prioritize drugs for repurposing
- Understanding how multi-targeted kinases can be pivoted towards new indications
|
|
|
| September 30, 2016 |
Webinar: Immuno-Oncology Drug Development: Profiling Immunomodulatory Biologics and Compounds in Human Primary Cell-Based Oncology Models - 60 min.
What will be covered?
- Overview of the BioMAP® immuno-oncology/oncology systems
- Information BioMAP iOnc studies provide
- Host stromal/vascular - tumor microenvironment biology
- Case studies of profiling Ab therapies (anti-PD-1, anti-CTLA-4, etc.) and preclinical compounds
|
|
|
| May 25, 2016 |
Webinar: A Phenotypic Platform for Characterization of Drug Safety Mechanisms in Human Primary Cell Disease Models - 40 min.
What will be covered?
- How to maximize knowledge of your compounds using the BioMAP® Diversity PLUS™ panel of human primary cells systems
- How to understand mechanism classification analysis and toxicity signatures
- A case study on discovery of a mechanism-based novel signature for skin irritation
|
|
|